Organogenesis Holdings Inc. (ORGO)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$2.42
+1.05%
Mkt Cap $302.31M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $172.65M | $225.07M | +30.36% | $0.21 | $0.31 | +44.19% | — | — |
| Q4 2025 Nov 6, 2025 | $172.68M | $150.86M | -12.63% | $0.21 | $0.18 | -14.29% | — | — |
| Q3 2025 Aug 7, 2025 | $134.10M | $101.00M | -24.68% | $0.07 | -$0.09 | -228.57% | — | — |
| Q2 2025 May 8, 2025 | $90.77M | $86.69M | -4.49% | $0.04 | -$0.13 | -425.00% | — | — |
| Q1 2025 Feb 27, 2025 | $109.60M | $126.66M | +15.56% | -$0.03 | $0.04 | +233.33% | — | — |
| Q4 2024 Nov 12, 2024 | $106.93M | $115.18M | +7.71% | $0.01 | $0.09 | +700.00% | — | — |
| Q3 2024 Aug 8, 2024 | $121.85M | $130.23M | +6.88% | -$0.02 | -$0.13 | -550.00% | — | — |
| Q2 2024 May 9, 2024 | $101.05M | $109.98M | +8.83% | -$0.02 | -$0.02 | -25.00% | — | — |
| Q1 2024 Feb 29, 2024 | $109.05M | $99.65M | -8.62% | -$0.00 | -$0.00 | -100.47% | — | — |
| Q4 2023 Nov 9, 2023 | $107.20M | $108.53M | +1.24% | $0.01 | $0.02 | +300.00% | — | — |
| Q3 2023 Aug 9, 2023 | $115.10M | $117.32M | +1.93% | $0.03 | $0.04 | +60.00% | — | — |
| Q2 2023 May 10, 2023 | $95.50M | $107.64M | +12.71% | -$0.02 | -$0.02 | +0.00% | — | — |
| Q1 2023 Mar 1, 2023 | $122.40M | $115.52M | -5.62% | $0.05 | $0.06 | +20.00% | — | — |
| Q4 2022 Nov 9, 2022 | $120.85M | $116.86M | -3.30% | $0.06 | $0.04 | -33.33% | — | — |
| Q3 2022 Aug 9, 2022 | $120.91M | $121.40M | +0.41% | $0.08 | $0.07 | -12.50% | — | — |
| Q2 2022 May 10, 2022 | $95.95M | $98.12M | +2.26% | $0.05 | $0.01 | -80.00% | — | — |
| Q1 2022 Mar 1, 2022 | $124.71M | $128.56M | +3.08% | $0.08 | $0.39 | +387.50% | — | — |
| Q4 2021 Nov 9, 2021 | $112.67M | $113.75M | +0.96% | $0.06 | $0.10 | +66.67% | — | — |
| Q3 2021 Aug 9, 2021 | $98.01M | $123.20M | +25.70% | $0.07 | $0.15 | +114.29% | — | — |
| Q2 2021 May 10, 2021 | $507.63M | $102.55M | -79.80% | $0.01 | $0.07 | +400.00% | — | — |